The future of dermatology

Dermatology Times, Dermatology Times, January 2019 (Vol. 40, No. 1), Volume 40, Issue 1

In this article, we take a look at the future of dermatology, including the rise of medical devices and drug costs. is reporting that the global dermatology devices market will continue to grow through 2027 with a rise in aesthetic procedures, an increasing need for early diagnosis and additional growth and investment opportunities.

The global report-Global Dermatology Devices Market Analysis and Trends, Industry Forecast to 2027-is based on an assessment of markets in 23 countries, including the U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, and South Africa.

The company’s Global Dermatological Drugs Market Report predicts that through 2022, the cost of dermatology drugs will continue to rise while the market will grow by 11.9 percent.

According to the report, “one driver influencing this market is the emergence of improved diagnostic modalities. One challenge affecting this market is the presence of access barriers for novel biologics and biosimilars. The originators (biologics manufacturers) have extended their current monopoly profits by creating several legal and regulatory barriers to the entry of biosimilars as they restrict the adoption of biologics.”